Thermo Fisher Scientific expands global capacity fight COVID-19

Thermo Fisher Scientific expands global capacity to fight COVID-19

11:06 AM, 28th July 2020
Molecule-Background
COVID-19 molecule

MUMBAI, INDIA: Thermo Fisher Scientific, the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting over 200 projects globally.
The company has expanded capacity for customers who are developing new and existing therapies, including promising anti-viral drugs, to meet increased demand and enable biopharma customers to significantly compress timelines for delivery to patients.In addition to its work on COVID-19-related vaccines and therapies, the company continues to ensure that patients undergoing clinical trials continue to receive the critical medicines they need. A "site to patient" program, launched at the start of the pandemic, has ensured clinical trial patients have uninterrupted access to life-saving investigational drug shipments without having to visit a clinic, one of many efforts to maintain supply chain continuity during the pandemic.

“Even before the pandemic, the company was strategically increasing its manufacturing, research and development capabilities, in addition to providing critical products and solutions for treating cancer, genetic diseases and other serious health concerns. Today, these initiatives are proving to be decisive in enabling our response to COVID-19 in India. We are well-positioned to extend our end-to-end workflow solutions for COVID-19 and quickly ramp up testing infrastructure and vaccine research and manufacturing,” said Amit Chopra, managing director, India & Middle East, Thermo Fisher Scientific.Thermo Fisher is also supporting multiple vaccine programs globally that are in or entering human clinical trials, providing critical capacity and expertise that has accelerated development and readiness by months.“Our investments in building capacity and capabilities demonstrate our commitment to fulfill our mission to enable our customers to make the world healthier, cleaner and safer,” said Chopra.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Indian Oil, Total to form bitumen derivatives JV in India

MUMBAI, INDIA: Indian Oil Corporation and Paris, France-based Total said they have formed a 50:50 joint venture (JV) company that will manufacture and ...

Read more
Schlumberger to cut 21,000 jobs; sees worst quarter in decades

HOUSTON, US: Schlumberger is cutting 21,000 jobs, or around one-fifth of its total workforce, as part of structural changes in response to one of its ...

Read more
Kiri to close dyes intermediate plant on pollution board directive

MUMBAI, INDIA: Kiri Industries Ltd said as per directives issued by Gujarat Pollution Control Board (GPCB), the company has closed one of its units - ...

Read more
Dow to reduce workforce as COVID-19 impacts earnings

MIDLAND, US: In an effort to preserve cash as the global economy fitfully recuperates from the COVID-19 pandemic, The Dow Chemical Company is reducing ...

Read more
Ultra-black fish that can disappear in deep seas

WASHINGTON DC, US: Deep in the ocean, where sunlight barely reaches, Smithsonian scientists and a team of collaborators have discovered one of the bla ...

Read more
COVID-19: Soorty selects Archroma colors for new denim collection

REINACH, SWITZERLAND: As part of its active engagement in the fight against COVID-19, Archroma announced a collaboration with Soorty for the developme ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X